Skip to main content
. 2023 Jun 15;9(6):e16930. doi: 10.1016/j.heliyon.2023.e16930

Fig. 5.

Fig. 5

Protein immune blot results (5-A) of p-JNK, and beta actin and respective bar graph of p-JNK (5-B) for the treatment groups. P-JNK pathway was up-regulated in scopolamine-treated group compared to the control group which was down-regulated by folicitin as seen in scopolamine plus folicitin-injected group and folicitin-treated group.